Key facts
- BioConsortia’s last known valuation is $136.0M (Aug 2025).
- It has raised $79.0M across 4 recorded rounds; the latest was Early Stage VC ($15.0M) in Apr 2023.
- Notable investors include Plug and Play Tech Center, Khosla Ventures, Otter Capital, Outset Ventures, Veronica Mason.
- BioConsortia has filed 5 Form Ds with the SEC since 2016, most recently Apr 2023 ($15.0M sold to 1 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for BioConsortia
Funding rounds
4 roundsAbout BioConsortia
Developer of microbial-based agricultural technologies designed to improve crop performance and sustainability. The company utilizes advanced gene discovery, trait mapping, and microbial selection techniques to develop products that enhance nitrogen fixation, bio-pesticide activity, and plant growth under stress, enabling farmers to increase yield, reduce chemical inputs and support soil health through targeted microbial solutions integrated into existing agricultural practices.
- Sector
- Materials and Resources
- HQ
- Davis, CA, United States
- Founded
- 2014
- Employees
- 50
- Website
- bioconsortia.com/
- Ownership
- Privately Held (backing)
BioConsortia doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BioConsortia shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BioConsortia in its N-PORT filings yet. We sweep new filings monthly.